Oncobiologics (NASDAQ:OTLK – Get Free Report) and Pasithea Therapeutics (NASDAQ:KTTA – Get Free Report) are both small-cap healthcare companies, but which is the better business? Get Oncobiologics alerts:ProfitabilityThis table compares Oncobiologics and Pasithea Therapeutics’ net margins, return on equity and return on assets. Analyst RatingsThis is a summary of current ratings and recommmendations for Oncobiologics and Pasithea Therapeutics, as reported by MarketBeat. Given Pasithea Therapeutics’ stronger consensus rating and higher probable upside, analysts plainly believe Pasithea Therapeutics is more favorable than Oncobiologics. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.